VLA Income and Expenditure 2006/07

Total Income £110.9m

Total income £110.9m

Site Navigation
Overview	Programmes
Chief Executive’s Overview	Emerging Diseases and Welfare
VLA Divisional Directors	Food and Environmental Safety
VLA Management Structure	International Trade
VLA - A Dynamic Organisation	Statutory and Exotic Bacterial Diseases
Features	Statutory and Exotic Viral Diseases
Epizone - One Year On	Transmissible Spongiform Encephalopathies
Med-Vet-Net-Success	Commercial Programme
Antimicrobial Resistance	Test Development
New Micro-array 'Chips'	Services
TB Diagnosis in the Field	Business Division
Spy Radiation - Major Alert	Papers
Financial	Emerging Diseases and Welfare
VLA Income and Expenditure 2006’07	Food and Environmental Safety
Awards	International Trade
Qualifications and Awards	Statutory and Exotic Bacterial Diseases
Other	Statutory and Exotic Viral Diseases
Homepage	Transmissible Spongiform Encephalopathies
Contact Us	Test Development
Site map